NFKB1 and cancer: Dysregulations of NF-kB signaling are a critical component in the development of various cancers [20], and NKILA suppresses the NF-kB signaling pathway by obstructing IKK directed IκB phosphorylation through direct binding at the p65—N terminal region of IkB.